Ryght AI, a startup using agentic AI to automate clinical trials, raised a $3 million seed round, co-founder and CEO Simon Arkell tells Axios Pro exclusively.
Ryght AI, a startup using agentic AI to automate clinical trials, raised a $3 million seed round, co-founder and CEO Simon Arkell tells Axios Pro exclusively.
Read more on Axios.
Synthetica Bio taps into generative AI and strategic partnerships to revolutionize drug discovery. This innovation aims to empower biopharma...
Ryght AI partners with USC’s Keck School of Medicine to launch a global clinical trial network, streamlining trials with AI for faster patient care.
Ryght AI is building what it calls the world’s first “agentic AI platform” for clinical trials. The company’s system automates site selection,...